<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d282">
    <sentence id="DDI-DrugBank.d282.s0" text="DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.">
        <entity id="DDI-DrugBank.d282.s0.e0" charOffset="0-7"
            type="brand" text="DOSTINEX"/>
        <entity id="DDI-DrugBank.d282.s0.e1" charOffset="78-91"
            type="group" text="phenothiazines"/>
        <entity id="DDI-DrugBank.d282.s0.e2" charOffset="94-107"
            type="group" text="butyrophenones"/>
        <entity id="DDI-DrugBank.d282.s0.e3" charOffset="110-122"
            type="group" text="thioxanthines"/>
        <entity id="DDI-DrugBank.d282.s0.e4" charOffset="128-141"
            type="drug" text="metoclopramide"/>
        <ddi id="DDI-DrugBank.d282.s0.d0" e1="DDI-DrugBank.d282.s0.e0"
            e2="DDI-DrugBank.d282.s0.e1" type="advise"/>
        <ddi id="DDI-DrugBank.d282.s0.d1" e1="DDI-DrugBank.d282.s0.e0"
            e2="DDI-DrugBank.d282.s0.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d282.s0.d2" e1="DDI-DrugBank.d282.s0.e0"
            e2="DDI-DrugBank.d282.s0.e3" type="advise"/>
        <ddi id="DDI-DrugBank.d282.s0.d3" e1="DDI-DrugBank.d282.s0.e0"
            e2="DDI-DrugBank.d282.s0.e4" type="advise"/>
    </sentence>
</document>
